Author

K. Raute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

S. Minguet· 2 shared A.-M. Schaffer· 1 shared G. Andrieux· 1 shared G. J. Fiala· 1 shared H. Zhou· 1 shared J. F. Hummel· 1 shared J. Maurer· 1 shared J. Strietz· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

S. Minguet

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Kidins220 promotes thymic iNKT cell development by reducing TCR signals, but enhances TCR signals in splenic iNKT cells

L. A. Herr, G. J. Fiala, A.-M. Schaffer, K. Raute, R. M.-H. Velasco Cardenas, J. F. Hummel, K. Ebert, Y. Tanriver, S. Minguet, W. W. Schamel

This study shows Kidins220 modulates TCR signaling in thymic and splenic iNKT cells, promoting development in the thymus by reducing TCR signals but enhancing TCR signals in the periphery.

bioRxiv · Apr 5, 2022 · PreprintImmunology

Breast cancer stem cell-derived tumors escape from γδ T cell immunosurveillance in vivo by modulating γδ T cell ligands

K. Raute, J. Strietz, G. Andrieux, O. S. Thomas, K. M. Kistner, M. Zintchenko, P. Aichele, H. Zhou, W. Weber, M. Boerries, M. Swamy, J. Maurer, S. Minguet

This study shows that breast cancer stem cells escape γδ T cell immunosurveillance by losing key ligands and antigens, and that this escape can be reversed with Zoledronate or IFN- treatment.

bioRxiv · Apr 4, 2022Immunology